Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Krapez, J. A.
Right arrow Articles by Balen, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krapez, J. A.
Right arrow Articles by Balen, A. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol 13, 3363-3367, Copyright © 1998 by Oxford University Press

ARTICLES

Survey of the diagnosis and management of antisperm antibodies

JA Krapez, CJ Hayden, AJ Rutherford and AH Balen
Reproductive Medicine Unit, Leeds General Infirmary, West Yorkshire, UK.

A questionnaire was sent to all Human Fertilization and Embryology Authority-registered reproductive medicine centres throughout the UK to survey their policy for the diagnosis and management of antisperm antibodies. Forty-eight responses were received from the 74 units that use husbands' spermatozoa for treatments (65%). Most centres use at least one test to detect antibodies, although a minority perform no tests on the basis that their clinical practice would be unaltered if antibodies were present. Positive tests are classed as clinically significant at levels varying from > or = 10% to > or = 50% for direct sperm binding tests (mixed antiglobulin reaction, immunobead test), and ranging from any positive reaction to > or = 1:32 for the microtitre tests (gelatin and tray agglutination tests, microimmobilization test). Strategies for managing affected patients include no intervention, artificial insemination and intrauterine insemination (IUI) using spermatozoa prepared by various techniques, in-vitro fertilization (IVF) with or without increased insemination concentration, and intracytoplasmic sperm injection. Criteria for the latter are diverse, some centres managing all antibody-positive patients this way, while others resort to it only in severe cases or after other treatments have failed. Half of the respondents occasionally or regularly employ steroids, either alone or in conjunction with IUI or IVF. Overall, it appears that much confusion exists as to how best to manage couples presenting with antibody-related infertility.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
C. Bohring and W. Krause
Immune infertility: towards a better understanding of sperm (auto)-immunity: The value of proteomic analysis
Hum. Reprod., May 1, 2003; 18(5): 915 - 924.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
G. S. Ghazeeri and W. H. Kutteh
Immunological testing and treatment in reproduction: frequency assessment of practice patterns at assisted reproduction clinics in the USA and Australia
Hum. Reprod., October 1, 2001; 16(10): 2130 - 2135.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
T. Hjort
Antisperm antibodies: Antisperm antibodies and infertility: an unsolvable question?
Hum. Reprod., October 1, 1999; 14(10): 2423 - 2426.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
W. H. Kutteh
Antisperm antibodies: Do antisperm antibodies bound to spermatozoa alter normal reproductive function?
Hum. Reprod., October 1, 1999; 14(10): 2426 - 2429.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
F.M. Helmerhorst, M.J.J. Finken, and J.J. Erwich
Antisperm antibodies: Detection assays for antisperm antibodies: what do they test?
Hum. Reprod., July 1, 1999; 14(7): 1669 - 1671.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.